Milder chemotherapy proves effective for rare, aggressive lymphoma

Most patients with a rare and aggressive form of large B-cell lymphoma can safely receive a less toxic treatment than the ...
News-Medical.Net on MSN

Most T-cell/histocyte-rich large B-cell lymphoma patients can safely receive a less toxic treatment

Most patients with a rare and aggressive form of large B-cell lymphoma can safely receive a less toxic treatment than the ...
Woman's World on MSN

7 thyroid medication side effects that mean your dose is dangerously high

Are you or someone you love among the 23 million Americans who take meds to treat hypothyroidism? Then we're here with a ...

Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new data highlighting the potential of ...

Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT)

Genmab A/S (Nasdaq: GMAB) today announced new and updated data from three arms of the ongoing Phase 1b/2 EPCORE® CLL-1 trial (NCT04623541) evaluating the efficacy and safety of epcoritamab-bysp, a ...